Skip to main content

Advertisement

SpringerLink
Log in

Is CD147 a New Biomarker Reflecting Histological Malignancy of Gliomas?

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

CD147 belongs to immunoglobulin superfamily and can stimulate the surrounding fibroblasts to secret matrix metalloproteinases (MMPs). Studies showed that when compared with their normal counterparts, CD47 expression level increased in lung carcinoma tissue, breast cancer tissue, and bladder cancer tissue. They increase in line with a tumor’s malignant progression, invasiveness, and metastasis. However, the precise implications and utility of the presence of CD147 in the WHO grading system for gliomas have rarely been reported; in addition, the signal transduction pathways regarding CD147 remain unclear and controversial. Thus, in performing a meta-analysis, it is essential to reach a reliable conclusion. The related literatures were incorporated into the present meta-analysis after careful assessment, and odds ratios (ORs) with 95 % confidence intervals (95 % CIs) were calculated. Heterogeneity evaluation was estimated. Ten studies involving 615 patients were found to be eligible, nine of which were conducted in China and the remaining one in Japan. Analysis of eight studies involving dichotomous data revealed that CD147 overexpression in glioma tissue was related to higher WHO grading (III + IV; OR, 9.900; 95 % CI, 5.943, 16.491; P = 0.000) closely, whereas analysis of three studies of continuous data type indicated that there were no statistical associations (standard mean difference, −1.894; 95 % CI, −4.081, 0.293; P = 0.090). In accordance with funnel plot, Egger test, and Begg test, there was no publication bias. Considering that the continuous data make up only a small proportion of the overall analysis, we believe that our study indicates that CD147 overexpression is potentially related to higher WHO grade. Certainly, more data compiled based on evidence-based medicine are required to further support this conclusion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Taal W, Bromberg JE, van den Bent MJ (2015) Chemotherapy in glioma. CNS Oncol 4:179–192

  2. Venneti S, Huse JT (2015) The evolving molecular genetics of low-grade glioma. Adv Anat Pathol 22:94–101

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Sameshima T, Nabeshima K, Toole BP et al (2000) Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Int J Cancer 88:21–27

    Article  CAS  PubMed  Google Scholar 

  4. Liang YX, Mo RJ, He HC et al (2015) Aberrant hypomethylation-mediated CD147 overexpression promotes aggressive tumor progression in human prostate cancer. Oncol Rep 33:2648–2654

    CAS  PubMed  Google Scholar 

  5. Kaira K, Arakawa K, Shimizu K et al (2015) Relationship between CD147 and expression of amino acid transporters (LAT1 and ASCT2) in patients with pancreatic cancer. Am J Transl Res 7:356–363

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Chu D, Zhu S, Li J et al (2014) CD147 expression in human gastric cancer is associated with tumor recurrence and prognosis. PLoS One 9:e101027

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kong LM, Liao CG, Zhang Y et al (2014) A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis. Cancer Res 74:3764–3778

    Article  CAS  PubMed  Google Scholar 

  8. Fei F, Li X, Xu L et al (2014) CD147-CD98hc complex contributes to poor prognosis of non-small cell lung cancer patients through promoting cell proliferation via the PI3K/Akt signaling pathway. Ann Surg Oncol 21:4359–4368

    Article  PubMed  Google Scholar 

  9. Li H, Chen J, He M, Hui XH, Cai BW, Li Y (2007) Expression of CD147 and MMP-2 in human gliomas and its correlations with prognosis. Sichuan Da Xue Xue Bao Yi Xue Ban 38:396–399

    CAS  PubMed  Google Scholar 

  10. Gu J, Zhang C, Chen R et al (2009) Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas. Eur J Pediatr 168:705–710

    Article  CAS  PubMed  Google Scholar 

  11. Sameshima T, Nabeshima K, Toole BP et al (2000) Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett 157:177–184

    Article  CAS  PubMed  Google Scholar 

  12. Steels E, Paesmans M, Berghmans T et al (2001) Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J 18:705–719

    Article  CAS  PubMed  Google Scholar 

  13. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560

    Article  PubMed  PubMed Central  Google Scholar 

  14. Wang D, Mou ZY, Zhai JX, Zong HX, Zhao XD (2008) Application of Stata software to test heterogeneity in meta-analysis method. Zhonghua Liu Xing Bing Xue Za Zhi 29:726–729

    CAS  PubMed  Google Scholar 

  15. Dickersin K, Berlin JA (1992) Meta-analysis: state-of-the-science. Epidemiol Rev 14:154–176

    Article  CAS  PubMed  Google Scholar 

  16. Stuck AE, Rubenstein LZ, Wieland D (1998) Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ 316(469):470–471

    Google Scholar 

  17. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA 295:676–680

    Article  CAS  PubMed  Google Scholar 

  18. Khayati F, Perez-Cano L, Maouche K, et al (2015) EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF. Oncotarget 6:9766–9780

  19. Milia-Argeiti E, Mourah S, Vallee B et al (1840) EMMPRIN/CD147-encriched membrane vesicles released from malignant human testicular germ cells increase MMP production through tumor-stroma interaction. Biochim Biophys Acta 2014:2581–2588

    Google Scholar 

  20. Rockwell S, Kimler BF, Moulder JE (2006) Publishing negative results: the problem of publication bias. Radiat Res 165:623–625

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan Hutong of Dongcheng District, Beijing, 100730, China

    Xiangyi Kong, Yu Wang, Congxin Dai, Wenbin Ma & Renzhi Wang

Authors
  1. Xiangyi Kong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Congxin Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wenbin Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Renzhi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Renzhi Wang.

Ethics declarations

Conflict of Interest

The authors state that there are no conflicts of interest to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kong, X., Wang, Y., Dai, C. et al. Is CD147 a New Biomarker Reflecting Histological Malignancy of Gliomas?. Mol Neurobiol 54, 1568–1576 (2017). https://doi.org/10.1007/s12035-016-9894-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-016-9894-2

Keywords

Search

Navigation